Hemmo Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1979.
1979 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 07 November 1979 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U17100MH1979PTC021857. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.91 M.

Formerly known as Jashan Textile Mills Private Limited. It upholds a compliant status. Employing 325 professional, Its leadership includes Surinder Bhawanidas Gulati (Director), Madhu Vikram Utamsingh (Director), Amit Anant Bapat (Director). Past directors included Rekha Jairam Hemrajani, Surinder Bhawanidas Gulati, Savita Jairam Hemrajani. It holds ₹25.00 Cr open charges and ₹1.06 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 114, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi,, Mumbai, Maharashtra, 400011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U17100MH1979PTC021857

  • Registration Number

    021857

  • Incorporation Date

    07 November 1979

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹2.91 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 2.91 M
  • Company Age 46 Year, 4 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 25.00 Cr
  • Satisfied Charges ₹ 1.06 Cr
  • Revenue Growth **** 44.62%
  • Profit Growth **** 68.07%
  • Ebitda **** 115.54%
  • Net Worth 39.37%
  • Total Assets **** 38.40%
Company report

Hemmo Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hemmo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hemmo Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Surinder Bhawanidas Gulati Director 22 Jun 2021 Current
Madhu Vikram Utamsingh Director 01 Aug 2008 Current
Amit Anant Bapat Director 26 Nov 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jun 2021 Past
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Director 19 Jun 2019 Past
Pramod Abcsdd Managing Director 22 Jun 2021 Past
Pramod Abcsdd Director 22 Jun 2021 Past
Pramod Abcsdd Additional Director 26 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hemmo Pharmaceuticals.

Hemmo Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.62% increase. The company also saw a substantial improvement in profitability, with a 68.07% increase in profit. The company's net worth Soared by an impressive increase of 39.37%.

Hemmo Pharmaceuticals revenue growth over time
Hemmo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 44.62%
*******
*******
*******
*******
Revenue from Operations
*******
 56.79%
*******
*******
*******
*******
Total Assets
*******
 38.40%
*******
*******
*******
*******
Profit or Loss
*******
 68.07%
*******
*******
*******
*******
Net Worth
*******
 39.37%
*******
*******
*******
*******
EBITDA
*******
 115.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hemmo Pharmaceuticals?

In 2021, Hemmo Pharmaceuticals had a promoter holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹250,000,000.00

Satisfied Charges

₹10,629,962.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 25.00 Cr
Latest Charge Details
Date Lender Amount Status
23 Mar 2022 Axis Bank Limited ₹25.00 Cr Open
22 Sep 1998 Indian Overseas Bank ₹0.32 M Satisfied
18 Sep 1995 Oriental Bank Of Commerce ₹5.00 M Satisfied
03 Oct 1992 Oriental Bank Of Commerce ₹2.00 M Satisfied
19 May 1992 Oriental Bank Of Commerce ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hemmo Pharmaceuticals?

Hemmo Pharmaceuticals has a workforce of 325 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemmo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemmo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hemmo Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 250.00 M with Charge ID 100561084 was registered on 23 Mar 2022. was documented.

  • Annual General Meeting

    Hemmo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Amit Anant Bapat was appointed as a Director was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Surinder Bhawanidas Gulati was appointed as a Director was appointed as a Director on 22 Jun 2021 & has been associated with this company since 4 years 8 months . was documented.

  • Balance Sheet

    The activity Hemmo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge registered on 22 Sep 1998 via Charge ID 90218208 with Indian Overseas Bank was fully satisfied on 11 Feb 2016. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hemmo Pharmaceuticals Private Limited?

The CIN of Hemmo Pharmaceuticals Private Limited is U17100MH1979PTC021857.

Where is Hemmo Pharmaceuticals Private Limited headquartered?

Hemmo Pharmaceuticals Private Limited is headquartered at 114, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi,, Mumbai, Maharashtra, 400011.

When was Hemmo Pharmaceuticals Private Limited incorporated?

Hemmo Pharmaceuticals Private Limited was incorporated on 07 November 1979.

Who are the current directors of Hemmo Pharmaceuticals Private Limited?

The current directors of Hemmo Pharmaceuticals Private Limited are

What is the primary industry of Hemmo Pharmaceuticals Private Limited?

The primary industry of Hemmo Pharmaceuticals Private Limited is Manufacturing.

Is Hemmo Pharmaceuticals Private Limited a listed company?

Hemmo Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Hemmo Pharmaceuticals Private Limited?

The authorized capital of Hemmo Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.91 M.

What is the compliance status of Hemmo Pharmaceuticals Private Limited?

The compliance status of Hemmo Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available